Publications | UCSF Philip R. Lee Institute for Health Policy Studies

Prognostic and Predictive Clinicopathologic Factors of Squamous Anal Canal Cancer in HIV-Positive and HIV-Negative Patients: Does HAART Influence Outcomes?

Pappou EP, Magruder JT, Fu T, Hicks CW, Herman JM, Fang S, Wick EC, Safar B, Gearhart SL, Efron JE

World J Surg 2018 Mar doi: 10.1007/s00268-017-4201-6

High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality.

Winestone LE, Punn R, Tamaresis JS, Buckingham J, Pinsky BA, Waggoner JJ, Kharbanda S

Pediatr Transplant 2018 Mar doi: 10.1111/petr.13084

Sex Differences in Health Care Utilization, End-Stage Renal Disease, and Mortality Among Medicaid Beneficiaries With Incident Lupus Nephritis.

Feldman CH, Broder A, Guan H, Yazdany J, Costenbader KH

Arthritis Rheumatol 2018 Mar doi: 10.1002/art.40392

A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults.

Mai NT, Dobbs N, Phu NH, Colas RA, Thao LT, Thuong NT, Nghia HD, Hanh NH, Hang NT, Heemskerk AD, Day JN, Ly L, Thu DD, Merson L, Kestelyn E, Wolbers M, Geskus R, Summers D, Chau NV, Dalli J, Thwaites GE

Elife 2018 Feb doi: 10.7554/eLife.33478

Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Henderson JT, Webber EM, Sawaya GF

JAMA 2018 Feb doi: 10.1001/jama.2017.21421

Paid Family and Childbearing Leave Policies at Top US Medical Schools.

Riano NS, Linos E, Accurso EC, Sung D, Linos E, Simard JF, Mangurian C

JAMA 2018 Feb doi: 10.1001/jama.2017.19519

Disparities in availability of essential medicines to treat non-communicable diseases in Uganda: A Poisson analysis using the Service Availability and Readiness Assessment.

Armstrong-Hough M, Kishore SP, Byakika S, Mutungi G, Nunez-Smith M, Schwartz JI

PLoS One 2018 Feb doi: 10.1371/journal.pone.0192332

Modernizing the World Health Organization List of Essential Medicines for Preventing and Controlling Cardiovascular Diseases.

Kishore SP, Blank E, Heller DJ, Patel A, Peters A, Price M, Vidula M, Fuster V, Onuma O, Huffman MD, Vedanthan R

J Am Coll Cardiol 2018 Feb doi: 10.1016/j.jacc.2017.11.056

Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes.

Ericsson Å, Glah D, Lorenzi M, Jansen JP, Fridhammar A

PLoS One 2018 Feb doi: 10.1371/journal.pone.0191953

Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.

Jafri K, Ogdie A, Qasim A, Patterson SL, Gianfrancesco M, Izadi Z, Katz P, Yazdany J, Schmajuk G

Clin Rheumatol 2018 Feb doi: 10.1007/s10067-017-3860-x